ticlopidine has been researched along with Rhabdomyolysis in 5 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report the case of an orthotopic heart transplant recipient who developed rhabdomyolysis precipitated by the addition of clopidogrel to the existing regimen of cyclosporine and atorvastatin, which had been tolerated for more than 3 years without adverse effects or laboratory evidence of myositis." | 7.74 | Clopidogrel-precipitated rhabdomyolysis in a stable heart transplant patient. ( Burton, I; Burton, JR; Pearson, GJ, 2007) |
| "To report the case of an orthotopic heart transplant recipient who developed rhabdomyolysis precipitated by the addition of clopidogrel to the existing regimen of cyclosporine and atorvastatin, which had been tolerated for more than 3 years without adverse effects or laboratory evidence of myositis." | 3.74 | Clopidogrel-precipitated rhabdomyolysis in a stable heart transplant patient. ( Burton, I; Burton, JR; Pearson, GJ, 2007) |
| " In a replication effort that used the US Food and Drug Administration (FDA) Adverse Event Reporting System (AERS), it was found that clopidogrel was used more commonly in patients with rhabdomyolysis receiving cerivastatin (17%) than in those receiving atorvastatin (0%, OR infinity; 95% CI = 5." | 1.38 | A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel. ( Floyd, JS; Heckbert, SR; Kaspera, R; Kwok, PY; Lumley, T; Marciante, KD; Psaty, BM; Tamraz, B; Totah, RA; Weiss, NS; Wiggins, KL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Floyd, JS | 1 |
| Kaspera, R | 1 |
| Marciante, KD | 1 |
| Weiss, NS | 1 |
| Heckbert, SR | 1 |
| Lumley, T | 1 |
| Wiggins, KL | 1 |
| Tamraz, B | 1 |
| Kwok, PY | 1 |
| Totah, RA | 1 |
| Psaty, BM | 1 |
| Uber, PA | 1 |
| Mehra, MR | 1 |
| Park, MH | 1 |
| Scott, RL | 1 |
| Von Scheidt, W | 1 |
| Burton, JR | 1 |
| Burton, I | 1 |
| Pearson, GJ | 1 |
| Vera, M | 1 |
| Pou, M | 1 |
| Botey, A | 1 |
| Cases, A | 1 |
5 other studies available for ticlopidine and Rhabdomyolysis
| Article | Year |
|---|---|
A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Cas | 2012 |
Clopidogrel and rhabdomyolysis after heart transplantation.
Topics: Clopidogrel; Drug Interactions; Heart Transplantation; Humans; Male; Middle Aged; Platelet Aggregati | 2003 |
[Interaction of statins with clopidogrel].
Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Biotransformation; Cause of Death; Clinica | 2004 |
Clopidogrel-precipitated rhabdomyolysis in a stable heart transplant patient.
Topics: Clopidogrel; Cyclosporine; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Middle | 2007 |
[Massive rhabdomyolysis associated with the use of cerivastatin monotherapy].
Topics: Anticholesteremic Agents; Anuria; Clopidogrel; Coronary Artery Bypass; Humans; Hypercholesterolemia; | 2001 |